| Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead D Kumar, A Ganeshpurkar, D Kumar, G Modi, SK Gupta, SK Singh European journal of medicinal chemistry 148, 436-452, 2018 | 169 | 2018 |
| The evolving landscape of exosomes in neurodegenerative diseases: exosomes characteristics and a promising role in early diagnosis S Rastogi, V Sharma, PS Bharti, K Rani, GP Modi, F Nikolajeff, S Kumar International journal of molecular sciences 22 (1), 440, 2021 | 114 | 2021 |
| A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease YP Singh, H Rai, G Singh, GK Singh, S Mishra, S Kumar, S Srikrishna, ... European Journal of Medicinal Chemistry 215, 113278, 2021 | 70 | 2021 |
| Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease D Kumar, SK Gupta, A Ganeshpurkar, G Gutti, S Krishnamurthy, G Modi, ... European journal of medicinal chemistry 150, 87-101, 2018 | 67 | 2018 |
| A review on iron chelators as potential therapeutic agents for the treatment of Alzheimer’s and Parkinson’s diseases YP Singh, A Pandey, S Vishwakarma, G Modi Molecular diversity 23, 509-526, 2019 | 62 | 2019 |
| Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main … H Rai, A Barik, YP Singh, A Suresh, L Singh, G Singh, UY Nayak, ... Molecular Diversity 25, 1905-1927, 2021 | 52 | 2021 |
| α-Synuclein aggregation modulation: an emerging approach for the treatment of Parkinson's disease SK Singh, A Dutta, G Modi Future medicinal chemistry 9 (10), 1039-1053, 2017 | 49 | 2017 |
| Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease YP Singh, GNVC Tej, A Pandey, K Priya, P Pandey, G Shankar, PK Nayak, ... European Journal of Medicinal Chemistry 198, 112257, 2020 | 46 | 2020 |
| Mycobacterium tuberculosis IMPDH in complexes with substrates, products and antitubercular compounds M Makowska-Grzyska, Y Kim, SK Gorla, Y Wei, K Mandapati, M Zhang, ... PloS one 10 (10), e0138976, 2015 | 43 | 2015 |
| Near-infrared fluorescent probes as imaging and theranostic modalities for amyloid-beta and tau aggregates in Alzheimer’s disease H Rai, S Gupta, S Kumar, J Yang, SK Singh, C Ran, G Modi Journal of Medicinal Chemistry 65 (13), 8550-8595, 2022 | 42 | 2022 |
| A novel approach to correlate the salivary exosomes and their protein cargo in the progression of cognitive impairment into Alzheimer’s disease K Rani, S Rastogi, P Vishwakarma, PS Bharti, V Sharma, KM Renu, ... Journal of Neuroscience Methods 347, 108980, 2021 | 42 | 2021 |
| Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6 … G Modi, T Antonio, M Reith, A Dutta Journal of medicinal chemistry 57 (4), 1557-1572, 2014 | 40 | 2014 |
| Novel bivalent ligands for D2/D3 dopamine receptors: significant cooperative gain in D2 affinity and potency S Gogoi, S Biswas, G Modi, T Antonio, MEA Reith, AK Dutta ACS medicinal chemistry letters 3 (12), 991-996, 2012 | 39 | 2012 |
| Dendrimers as prospective nanocarrier for targeted delivery against lung cancer V Arora, MAS Abourehab, G Modi, P Kesharwani European Polymer Journal 180, 111635, 2022 | 38 | 2022 |
| Dopamine D3 Agonists in the Treatment of Parkinson&aposs Disease B Das, G Modi, A Dutta Current Topics in Medicinal Chemistry 15 (10), 908-926, 2015 | 37 | 2015 |
| Biomolecular basis of matrix metallo proteinase-9 activity R Swetha, C Gayen, D Kumar, TD Singh, G Modi, SK Singh Future medicinal chemistry 10 (9), 1093-1112, 2018 | 33 | 2018 |
| Drug repurposing for Alzheimer’s disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors N Kumar, A Gahlawat, RN Kumar, YP Singh, G Modi, P Garg Journal of Biomolecular Structure and Dynamics 40 (7), 2878-2892, 2022 | 29 | 2022 |
| Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates G Modi, C Voshavar, S Gogoi, M Shah, T Antonio, MEA Reith, AK Dutta ACS chemical neuroscience 5 (8), 700-717, 2014 | 28 | 2014 |
| Multicomponent Synthesis of S-Benzyl Dithiocarbamates from para-Quinone Methides and Their Biological Evaluation for the Treatment of Alzheimer’s Disease R Venkatesh, G Shankar, AC Narayanan, G Modi, S Sabiah, ... The Journal of Organic Chemistry 87 (10), 6730-6741, 2022 | 21 | 2022 |
| Further Structure−Activity Relationship Studies on 4-((((3S,6S)-6-Benzhydryltetrahydro-2H-pyran-3-yl)amino)methyl)phenol: Identification of Compounds with … B Gopishetty, S Hazeldine, S Santra, M Johnson, G Modi, S Ali, J Zhen, ... Journal of medicinal chemistry 54 (8), 2924-2932, 2011 | 21 | 2011 |
Yash Pal Singh, Ph.D.Department of Medicinal Chemistry, Virginia Commonwealth University在 vcu.edu 的电子邮件经过验证
